237 related articles for article (PubMed ID: 26875774)
1. Altered expression of miR-125a-5p in thymoma-associated myasthenia gravis and its down-regulation of foxp3 expression in Jurkat cells.
Li J; Qiu D; Chen Z; Du W; Liu J; Mo X
Immunol Lett; 2016 Apr; 172():47-55. PubMed ID: 26875774
[TBL] [Abstract][Full Text] [Related]
2. Analysis of microRNA expression in the thymus of Myasthenia Gravis patients opens new research avenues.
Cron MA; Maillard S; Delisle F; Samson N; Truffault F; Foti M; Fadel E; Guihaire J; Berrih-Aknin S; Le Panse R
Autoimmun Rev; 2018 Jun; 17(6):588-600. PubMed ID: 29655674
[TBL] [Abstract][Full Text] [Related]
3. Thymoma Associated Myasthenia Gravis (TAMG): Differential Expression of Functional Pathways in Relation to MG Status in Different Thymoma Histotypes.
Yamada Y; Weis CA; Thelen J; Sticht C; Schalke B; Ströbel P; Marx A
Front Immunol; 2020; 11():664. PubMed ID: 32373124
[TBL] [Abstract][Full Text] [Related]
4. Reduced miR-125a-5p expression is associated with gastric carcinogenesis through the targeting of E2F3.
Xu Y; Huang Z; Liu Y
Mol Med Rep; 2014 Nov; 10(5):2601-8. PubMed ID: 25231560
[TBL] [Abstract][Full Text] [Related]
5. miR-548k regulates CXCL13 expression in myasthenia gravis patients with thymic hyperplasia and in Jurkat cells.
Li J; Qiu D; Chen Z; Du W; Liu J; Mo X
J Neuroimmunol; 2018 Jul; 320():125-132. PubMed ID: 29661539
[TBL] [Abstract][Full Text] [Related]
6. A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells.
Leotta M; Biamonte L; Raimondi L; Ronchetti D; Di Martino MT; Botta C; Leone E; Pitari MR; Neri A; Giordano A; Tagliaferri P; Tassone P; Amodio N
J Cell Physiol; 2014 Dec; 229(12):2106-16. PubMed ID: 24819167
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-125a-5p plays a role as a tumor suppressor in lung carcinoma cells by directly targeting STAT3.
Zhong L; Sun S; Shi J; Cao F; Han X; Chen Z
Tumour Biol; 2017 Jun; 39(6):1010428317697579. PubMed ID: 28631574
[TBL] [Abstract][Full Text] [Related]
8. Role of miRNAs in Normal and Myasthenia Gravis Thymus.
Cron MA; Guillochon É; Kusner L; Le Panse R
Front Immunol; 2020; 11():1074. PubMed ID: 32587589
[TBL] [Abstract][Full Text] [Related]
9. Over-expression of miR-125a-5p inhibits proliferation in C2C12 myoblasts by targeting E2F3.
Song C; Wu G; Xiang A; Zhang Q; Li W; Yang G; Shi X; Sun S; Li X
Acta Biochim Biophys Sin (Shanghai); 2015 Apr; 47(4):244-9. PubMed ID: 25733534
[TBL] [Abstract][Full Text] [Related]
10. Suppression of microRNA-125a-5p upregulates the TAZ-EGFR signaling pathway and promotes retinoblastoma proliferation.
Zhang Y; Xue C; Zhu X; Zhu X; Xian H; Huang Z
Cell Signal; 2016 Aug; 28(8):850-60. PubMed ID: 27094723
[TBL] [Abstract][Full Text] [Related]
11. The LINC00452/miR-204/CHST4 Axis Regulating Thymic Tregs Might Be Involved in the Progression of Thymoma-Associated Myasthenia Gravis.
Wang F; Zhang H; Qiu G; Li Z; Wang Y
Front Neurol; 2022; 13():828970. PubMed ID: 35432149
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA MEG3 inhibits microRNA-125a-5p expression and induces immune imbalance of Treg/Th17 in immune thrombocytopenic purpura.
Li JQ; Hu SY; Wang ZY; Lin J; Jian S; Dong YC; Wu XF; Dai-Lan ; Cao LJ
Biomed Pharmacother; 2016 Oct; 83():905-911. PubMed ID: 27522004
[TBL] [Abstract][Full Text] [Related]
13. Thymic gene expression analysis reveals a potential link between HIF-1A and Th17/Treg imbalance in thymoma associated myasthenia gravis.
Altınönder İ; Kaya M; Yentür SP; Çakar A; Durmuş H; Yegen G; Özkan B; Parman Y; Sawalha AH; Saruhan-Direskeneli G
J Neuroinflammation; 2024 May; 21(1):126. PubMed ID: 38734662
[TBL] [Abstract][Full Text] [Related]
14. Curcumin exerts inhibitory effects on undifferentiated nasopharyngeal carcinoma by inhibiting the expression of miR-125a-5p.
Gao W; Chan JY; Wong TS
Clin Sci (Lond); 2014 Nov; 127(9):571-9. PubMed ID: 24896104
[TBL] [Abstract][Full Text] [Related]
15. Altered let-7 expression in Myasthenia gravis and let-7c mediated regulation of IL-10 by directly targeting IL-10 in Jurkat cells.
Jiang L; Cheng Z; Qiu S; Que Z; Bao W; Jiang C; Zou F; Liu P; Liu J
Int Immunopharmacol; 2012 Oct; 14(2):217-23. PubMed ID: 22835429
[TBL] [Abstract][Full Text] [Related]
16. MARK1 is a Novel Target for miR-125a-5p: Implications for Cell Migration in Cervical Tumor Cells.
Natalia MA; Alejandro GT; Virginia TJ; Alvarez-Salas LM
Microrna; 2018; 7(1):54-61. PubMed ID: 29076440
[TBL] [Abstract][Full Text] [Related]
17. miR-15b is Downregulated in Myasthenia Gravis Patients and Directly Regulates the Expression of Interleukin-15 (IL-15) in Experimental Myasthenia Gravis Mice.
Shi L; Liu T; Zhang M; Guo Y; Song C; Song D; Liu H
Med Sci Monit; 2015 Jun; 21():1774-80. PubMed ID: 26087886
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-125a-5p modulates human cervical carcinoma proliferation and migration by targeting ABL2.
Qin X; Wan Y; Wang S; Xue M
Drug Des Devel Ther; 2016; 10():71-9. PubMed ID: 26766902
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA and mRNA expression associated with ectopic germinal centers in thymus of myasthenia gravis.
Sengupta M; Wang BD; Lee NH; Marx A; Kusner LL; Kaminski HJ
PLoS One; 2018; 13(10):e0205464. PubMed ID: 30308012
[TBL] [Abstract][Full Text] [Related]
20. A plasma mir-125a-5p as a novel biomarker for Kawasaki disease and induces apoptosis in HUVECs.
Li Z; Jiang J; Tian L; Li X; Chen J; Li S; Li C; Yang Z
PLoS One; 2017; 12(5):e0175407. PubMed ID: 28467514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
